[ET Net News Agency, 18 October 2024] HANSOH PHARMA (03692) rose 4.3% to HK$21.9.
It hits an intra-day high of HK$22.05, and an intra-day low of HK$20.75. The total
shares traded was 4.24 million, with a value of HK$90.97m. The active buy/sell ratio is
56:44, with net buying turnover of HK$10.03m. GOLDMAN SACHS (ASIA) SEC accounts for
greatest net responsive buying turnover of HK$5.05m, with volume weighted average price of
HK$21.401. CHINA INT'L CAPITAL CORP HK accounts for greatest net responsive selling
turnover of HK$7.64m, with volume weighted average price of HK$21.518. The stock has risen
a combined 7.9% over the past 2 consecutive trading days.
The Hang Seng Index now rose 266 points, or 1.3% to 20,345.

Basic Information
=================

---------------------------------
Nominal 21.900 % Chg +4.29%
High 22.050 Low 20.750
Shares Tr 4.24m Turnover 90.97m
10-D SMA 21.000 %H.V 49.983
20-D SMA 20.733 VWAP 21.468
50-D SMA 19.530 RSI14 60.574
---------------------------------
Status: Active buy/sell ratio is 56:44, with net buying turnover of HK$10.03m, rising a
combined 7.9% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 21.90 +4.29
ALI HEALTH (00241) 3.77 +1.62
TRAD CHI MED (00570) 3.78 -4.30
CSPC PHARMA (01093) 6.18 +1.64
SINOPHARM (01099) 19.74 +1.23
SINO BIOPHARM (01177) 3.71 +2.77
WUXI APPTEC (02359) 48.90 +2.19
CHINARES PHARMA (03320) 5.65 +1.62
JD HEALTH (06618) 26.25 +0.38
GOLDEN THROAT (06896) 3.08 -0.32
-----------------------------------------------
(ed)